Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Penelope MacRae

Advertisement
Set Alert for Articles By Penelope MacRae

Latest From Penelope MacRae

Medtech Can Help India 'Leapfrog Health Care Constraints'

A new Deloitte report says medtech could help bridge the gap in India between the vast number of patients requiring health care and the small medical manpower available that’s led to a public health care crisis. However, the government needs to create a more conducive investment climate for medical device players to build this bridge.

Policy & Regulation India

Panacea Expands Apotex Tie-Up, Drives Earnings Recovery

Panacea Biotec is expanding its partnership with Apotex to launch a copycat version of Eli Lilly’s Effient in the US, part of an alliance-building strategy with global players that the Indian firm hopes can help pull it out of an earnings tailspin.

Commercial Deals

Strides Shasun Expands Australia Base With Amneal Deal

Indian drug firm Strides Shasun has acquired the Australian unit of Amneal Pharmaceuticals, extending its customer footprint as it sets sights on becoming the leading player in the Australian generics market.

Commercial Deals

India Must ‘Hike Health Spending Or Risk Slowdown’

A US healthcare advocacy group says India’s rapid economic growth will be jeopardized unless the country starts boosting investment to care for its 1.3bn population. It’s clear what the problems are, but India needs to move from ‘issue stating’ to problem solving, the group’s chairman, Kenneth Thorpe, told the Pink Sheet.

Policy Healthcare Systems

India Upholds Prevnar 13 Patent In Big Win For Pfizer

India has awarded Pfizer a patent for its blockbuster pneumonia vaccine Prevnar13, handing the pharmaceutical giant a big victory in a case which has been closely watched as a key test of the country’s patentability criteria.

Commercial Companies

India Strikes Pricing Blow To Knees After Stent Cuts

Six months after imposing stiff price controls on cardiac stents, India’s government slashed costs of knee implants by nearly 70%, saying the action was necessary to end “unethical profiteering.”

Orthopedics India
See All
Advertisement
UsernamePublicRestriction

Register